GnRH and miR-200b treatments boost cognition in Down syndrome
María Manfredi-Lozano, Valerie Leysen, Michela Adamo, Samuel A. Malone, Mauro S.B. Silva, Andrea Messina, Paolo Giacobini, Nelly Pitteloud, Vincent Prevot · FENS Forum 2024
Down syndrome (DS) patients who show mental retardation also present acquired anosmia, i.e., the loss of odor detection. At the present time, no viable treatment exists for cognitive and olfactory deficits in DS. Interestingly, the ability to reach puberty and become fertile is also affected in these patients. An intriguing candidate, whose absence could mediate most of these phenotypes, is the gonadotropin-releasing hormone (GnRH), the neurohormone controlling reproduction. However, whether GnRH plays a role in the age-related cognitive decline in DS is unknown.We showed in Ts65dn mice, a wel